Lexaria Bioscience Corp. — Regulatory Filings 2014

Jan 29, 2014

8-K 1 form8k.htm 8_K Lexaria Corp.: Form 8-K - Filed by newsfilecorp.com

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): January 29, 2014

LEXARIA CORP. (Exact name of registrant as specified in its charter)

Nevada	000-52138	20-2000871
(State or other jurisdiction of	(Commission File Number)	(IRS Employer Identification No.)
incorporation)

#950 – 1130 West Pender Street, Vancouver, British Columbia, Canada V6E 4A4

Registrant's telephone number, including area code: (604) 602-1675

________________________________________________ (Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a -12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d -2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under Exchange Act (17 CFR 240.13e -4(c))

$$/page=

Item 7.01 Regulation FD Disclosure.

On January 29, 2014 the Company announced an increase in its reserve report.

A copy of the news release announcing an update on the Belmont Lake well production filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

I TEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

| Exhibit

No.	Description
99.1	News Release dated
January 29, 2014

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: January 29, 2014

	Lexaria Corp.
(Signature)	By: “ /s/ Chris
Bunka”
	Chris Bunka
	President & CEO